A new partnership between CariGenetics Saint Lucia and Lab Services & Consultations could change how some diseases, like cancer, are diagnosed and treated in Saint Lucia.
The partnership aims to make genetic testing, advanced cancer diagnostics, and sequencing services easier to access, bringing technology that is often found only overseas closer to patients in Saint Lucia.
With access to tumour and special tissue testing, doctors will be able to better understand a patient’s cancer and choose the best treatment options.
“Immunohistochemistry and cancer tumour genetics is the difference between giving a patient generalised treatment and providing truly personalised, effective medicine,” said Dr Stephen King, laboratory director at Lab Services.
The partnership, which officially started on Wednesday, will also make it easier for people to access genetic testing if they want to learn about inherited health risks, how they might respond to certain medicines, and other information that can help with healthcare decisions.
Besides patient care, the initiative is expected to help Saint Lucia better prepare for future health challenges. Increased sequencing capacity can support disease surveillance, monitor antibiotic resistance and improve preparedness for emerging public health threats.
For Devy Frederick, CEO of CariGenetics Saint Lucia, making these services available is just one part of the equation. He stressed that it is equally important to ensure they translate into better patient care.
“The aim of this partnership therefore is not only to introduce new testing services but to ensure that they are properly connected to clinical care,” he said.
Although the services will first be available in Saint Lucia, both organisations see the partnership as part of a broader regional effort to expand access to advanced diagnostics across the OECS.
“What we are witnessing is more than the shaping of a business partnership,” said OECS Director General Dr Didacus Jules. “It is an act of intellectual sovereignty, a declaration that the Eastern Caribbean has the ambition, the talent, and now the infrastructure to participate meaningfully in the future of medicine.”
